novartis ag-sponsored adr (NVS:New York)
Chief Financial Officer and Member of Executive Committee, Novartis AG
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 1 different industries.|
As of Fiscal Year 2013
Mr. Harry Kirsch has been the Chief Financial Officer of Novartis AG since May 1, 2013. Mr. Kirsch joined Novartis in 2003 from Procter & Gamble. Mr. Kirsch studied industrial engineering and economics at the university of karlsruhe in Germany ("Diplom Wirtschaftsingenieur").
Lichtstrasse 35Phone: 41 61 324 11 11
Basel, Basel-Stadt 4056
Board Members Memberships*There is no Board Members Memberships data available.
Karlsruhe Institute of Technology
|John C. Martin Ph.D.||Chairman and Chief Executive Officer|
Gilead Sciences Inc.
|Alan George Lafley||Chairman, Chief Executive Officer, President and Member of Proxy Committee|
The Procter & Gamble Company
|Ian C. Read||Chairman, Chief Executive Officer and Chairman of Executive Committee|
|Kenneth C. Frazier||Chairman and Chief Executive Officer|
Merck & Co. Inc.
|Serge Weinberg||Chairman, Interim Chief Executive Officer, Chairman of Appointments & Governance Committee and Chairman of Strategy Committee|
|€700.0K||Compensation as of Fiscal Year 2013.|